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Vogt–Koyanagi–Harada (VKH) disease is a granulamatous
inflammatory disease affecting the eyes, auditory system,
meninges and the skin [1]. Although headache, a prodro-
mal sign, is present in 67% of patients [2], VKH disease is
rarely encountered in neurology practice [3, 4].
Case 1 A 22-year-old woman reported a sudden onset of
continuous severe headache followed by gradually evolved
bilateral blurred vision. An MRI of the brain and orbital
were normal. Analysis of CSF revealed monocytosis.
Neuroophthalmologic examination revealed swelling of the
optic disks and a cell reaction in vitreous and anterior
chamber (Fig. 1a, b). She was diagnosed as incomplete
VKH disease. For 10 days, 1 g/day intravenous methyl
prednisolone (IVMP) treatment was administered, follow-
ing an oral dose with 2 mg/kg per day. One week later, her
symptoms were completely improved. Steroid treatment
continued for 3 months with gradual decrease.
Case 2 A 47-year-old woman presented with a 3-week
history of diffuse and bilateral, orbito-retroorbital headache
and bilateral acute vision loss. Cranial CT, MRI and MR
angiography were normal. CSF pressure was normal.
Analysis of CSF revealed 90% of monocytosis. Her
funduscopic examination showed hyperemia and swelling
of the optic disk. She was diagnosed with incomplete
VKH. For ten days, 1 g/kg IVMP treatment was adminis-
tered. In the sixth day of the treatment headache and visual
complaints were improved. Treatment continued with high
dose oral steroid (2 mg/kg) and decreased gradually.
In patients with VKH disease meningeal involvement
may cause severe devastating headache mimicking other
types of acute headaches. Symptoms might be interpreted
as optic neuritis, pituitary apoplexy or intracranial hyper-
tension if headache is associated with ocular findings.
Moreover, integumentary symptoms such as allopesia,
poliosis, vitiligo appear only late at the convalescent stage
of the disease. Therefore, the diagnostic criteria lack sen-
sitivity for the early diagnosis of VKH disease particularly
in neurology emergencies. If the brain MRI is normal,
diagnosis could be more confusing. VKH disease should be
considered in the differential diagnosis of patients pre-
senting with acute headache followed by bilateral blurred
vision. Early diagnosis and adequate treatment are the keys
to success. Corticosteroid is essential in the management of
VKH disease.










J Headache Pain (2008) 9:255–256
DOI 10.1007/s10194-008-0045-7
References
1. Sugiura A (1978) Vogt–Koyanagi–Harada disease. Jpn J Ophthal-
mol 22:9–35
2. Cho HJ, Ahn YJ, Byeon SH et al (2008) Thunderclap headache as
initial manifestation of Vogt Koyanagi Harada disease. Headache
48:153–155
3. Mantovani A, Resta A, Herbort CP et al (2007) Work up, diagnosis
and management of acute Vogt Koyanagi Harada disease. Int
Ophthalmol 27:105–115
4. Read R, Rao NA, Cunningham ET (2000) Vogt Koyanagi Harada
disease. Curr Opin in Ophthalmol 11:437–442
Fig. 1 a Pathologic funduscopic examination with papilledema and
cell reaction in vitreous and anterior chamber. b Pathologic fundu-
scopic examination with papilledema and cell reaction in vitreous and
anterior chamber
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